Olav Larsen

Olav Larsen

Postdoc


  1. Published

    Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model

    Getschman, A. E., Imai, Y., Larsen, Olav, Peterson, F. C., Wu, X., Rosenkilde, M. M., Hwang, S. T. & Volkman, B. F., 2017, In: Proceedings of the National Academy of Sciences of the United States of America. 114, 47, p. 12460-12465 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration

    González-Motos, V., Jürgens, C., Ritter, B., Kropp, K. A., Durán, V., Larsen, Olav, Binz, A., Ouwendijk, W. J. D., Lenac Rovis, T., Jonjic, S., Verjans, G. M. G. M., Sodeik, B., Krey, T., Bauerfeind, R., Schulz, T. F., Kaufer, B. B., Kalinke, U., Proudfoot, A. E. I., Rosenkilde, Mette & Viejo-Borbolla, A., May 2017, In: PLOS Pathogens. 13, 5, 28 p., e1006346.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes

    Janssens, R., Mortier, A., Boff, D., Ruytinx, P., Gouwy, M., Vantilt, B., Larsen, Olav, Daugvilaite, V., Rosenkilde, Mette, Parmentier, M., Noppen, S., Liekens, S., Van Damme, J., Struyf, S., Teixeira, M. M., Amaral, F. A. & Proost, P., 2017, In: Biochemical Pharmacology. 132, p. 92-101 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 138841170